Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.86+0.08 (+0.82%)
Close on Nov 13, 2026Market cap $370.94MP/E –Yield –
Contineum Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Contineum Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was 32.2%. For fiscal 2023 it was 32.2%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 32.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | 77.9% | – |
See a number that looks wrong?